Company intelligence / Profile preview
KT&G
Seoul, Seoul Special City, South Koreaen.ktng.com ↗
- Ownership
- Public · 033780
- Development stage
- Commercial
01
Overview
KT&G Life Sciences is a South Korean biopharmaceutical company focused on innovative drug R&D. It was spun off from the larger conglomerate KT&G Corporation, which is best known globally for tobacco and ginseng products but has diversified into pharmaceuticals and biotechnology through subsidiaries like KT&G Life Sciences. The company’s pipeline includes several preclinical or early-stage drug candidates targeting inflammation, obesity, prostatitis, and xerophthalmia. No clinical results or approved drugs have been reported as of April 2025.
- Therapeutic areas
- EndocrinologyOphthalmologyImmunologyMen's Health
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Financials
- Market cap
- $14.6B
- Total revenue
- $4.9B
- Enterprise value
- $14.8B
Beyond the preview
Go deeper on KT&G.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KT&G.